HPV testing has evolved significantly with the introduction of high-risk HPV DNA tests and co-testing methods. These tests are more sensitive and specific than traditional Pap smears, enabling early detection of HPV-related abnormalities. This evolution has improved the management of cervical cancer, allowing for earlier intervention and better outcomes.
